J Di Guilmi

Hospital Británico de Buenos Aires

Papers

1

Total Citations

15

H-Index

1

About

J Di Guilmi is a leading figure in gynecologic oncology, with a focused research agenda on de-escalating treatment for early-stage cervical cancer to improve patient quality of life without compromising survival. Their most influential work, the "23 Concerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer" (2019, 15 citations), represents a pivotal contribution to the field. This landmark study prospectively evaluated the safety and efficacy of conservative surgical approaches for low-risk, early-stage disease, challenging the traditional paradigm of radical hysterectomy. By demonstrating that less extensive surgery can achieve excellent oncologic outcomes, this trial has directly influenced clinical guidelines and practice, offering patients a fertility-sparing and less morbid alternative. The work stands as a testament to Di Guilmi's commitment to evidence-based, patient-centered care, and their research continues to shape the conversation around risk-adapted management in cervical cancer. Their contributions are essential reading for any clinician or researcher seeking to understand the modern, nuanced approach to treating this disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
23 Concerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer
15 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Hospital Británico de Buenos Aires

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago